Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of "Risk Factor Stacking"
Publication
, Conference
Weycker, D; Li, X; Barron, R; Wu, H; Morrow, PK; Xu, H; Reiner, M; Garcia, J; Mhatre, S; Lyman, GH
Published in: BLOOD
2014
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
2014
Volume
124
Issue
21
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Weycker, D., Li, X., Barron, R., Wu, H., Morrow, P. K., Xu, H., … Lyman, G. H. (2014). Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of "Risk Factor Stacking". In BLOOD (Vol. 124).
Weycker, Derek, Xiaoyan Li, Rich Barron, Hongsheng Wu, Phuong Khanh Morrow, Hairong Xu, Maureen Reiner, Jacob Garcia, Shivani Mhatre, and Gary H. Lyman. “Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of "Risk Factor Stacking".” In BLOOD, Vol. 124, 2014.
Weycker D, Li X, Barron R, Wu H, Morrow PK, Xu H, et al. Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of "Risk Factor Stacking". In: BLOOD. 2014.
Weycker, Derek, et al. “Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of "Risk Factor Stacking".” BLOOD, vol. 124, no. 21, 2014.
Weycker D, Li X, Barron R, Wu H, Morrow PK, Xu H, Reiner M, Garcia J, Mhatre S, Lyman GH. Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of "Risk Factor Stacking". BLOOD. 2014.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
2014
Volume
124
Issue
21
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology